Decentralized Trials Guidance May Reflect US FDA’s Lessons Learned During COVID-19

 
• By Sue Sutter
  
stethoscope and a smartphone with a medical app, copyspace (3d render)
Decentralized trials offer a more patient-centric approach to data collection. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D